Prosecution Insights
Prosecution Insights
Tech Center 4100 • Art Units: 1623 1625 1626 1629 1699 4121
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18287844 | GluN2 Subunit Selective Antagonists of the N-Methyl-D-Aspartate Receptors | Non-Final OA | Emory University |
| 18571768 | HYDROGENATION OF ESTERS TO ALCOHOLS IN THE PRESENCE OF AN MN-PNN COMPLEX | Non-Final OA | BASF SE |
| 18265827 | POLYOXO NIOBATE COMPOUND DISPERSION AND METHOD FOR MANUFACTURING SAME | Non-Final OA | Mitsui Mining & Smelting Co., Ltd. |
| 18725600 | SMARCA2/4 INHIBITION AS A STRATEGY TO TREAT TUMORS THAT HARBOR ABERRANT BAF ASSEMBLIES | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17998909 | COMPOUNDS FOR THE TREATMENT OF SARS | Final Rejection | Purdue Research Foundation |
| 18426920 | SYNTHESIS OF NOVEL CEREBLON E3 LIGASE LIGANDS, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18785078 | PROCESS FOR THE MANUFACTURE OF A HER2 INHIBITOR | Non-Final OA | Boehringer Ingelheim International GmbH |
| 17131312 | ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS | Non-Final OA | Boehringer Ingelheim Vetmedica GmbH |
| 18266941 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | Final Rejection | LT MATERIALS CO., LTD. |
| 17928283 | COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF | Non-Final OA | Anima Biotech Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy